Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression

Published:2017-07-27 Issue:11 Volume:15 Page:1491-1502
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Anbalagan Muralidharan,Sheng Mei,Fleischer Brian,Zhang Yifang,Gao Yuanjun,Hoang Van,Matossian Margarite,Burks Hope E.,Burow Matthew E.,Collins-Burow Bridgette M.,Hangauer David,Rowan Brian G.

Funder

Louisiana Cancer Research Consortium

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenoxyalkyl cyclic and acyclic amine derivatives: what do they teach us about scaffold-based drug design?;Medicinal Chemistry Research;2024-04-10

2. Transcription factor support for the dual embryological origin of the sternocleidomastoid and trapezius muscles;Clinical Anatomy;2023-12-06

3. Peptidomimetics in cancer targeting;Molecular Medicine;2022-12

4. Network Analysis Identifies Potential Small-Molecule Drugs Sensitizing Triple-Negative Breast Cancer to Tamoxifen;Proceedings of the 2022 11th International Conference on Bioinformatics and Biomedical Science;2022-10-28

5. Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants;Frontiers in Pharmacology;2022-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP